 Connor Clark Lunn Investment Management Ltd. bought a new position in shares of Five Prime Therapeutics Inc NASDAQ:FPRX in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission SEC. The fund bought 20,540 shares of the biotechnology companys stock, valued at approximately 94,000. Connor Clark ... 